Earth Science Tech, Inc. (ETST) Reports Third Fiscal Quarter 2026 Results
Rhea-AI Summary
Earth Science Tech (OTC: ETST) reported Q3 fiscal 2026 results for the quarter ended December 31, 2025, with revenue of $8.4M (+14.1% YoY) and net income of $910K (+341% YoY). Gross profit rose $1.3M to $6.4M (76.3% margin). Adjusted EBITDA was $1.2M. Cash on hand fell to $416K as inventory and operations increased. The company reported Peaks telemedicine revenue surpassing $2.0M in under a year and repurchased shares during the period.
Positive
- Revenue +14.1% YoY to $8.4 million
- Net income +341% YoY to $910,000
- Adjusted EBITDA improved from $0.3M to $1.2M
- Peaks telemedicine surpassed $2.0M revenue in under a year
- Total assets increased 14.5% to $8.1M
- Working capital improved to $773,000
Negative
- Cash on hand declined from $1.5M to $416,000
- Inventory and operating activity consumed cash and reduced liquidity
- Revenue of
$8.4 million , up14.1% year-over-year - Gross profit margin of
76.3% , up 71 bps year-over-year - Net income of
$910,000 , up341% year-over-year - Generated positive cash from operations of
$1.2 million fiscal year-to-date - Peaks, the company’s telemedicine platform, surpasses
$2.0 million in revenue in less than a year, scaling from$248,000 into a high‑margin growth platform - Reduced outstanding shares of common stock by
3.6% year over year through share repurchases - Geographic expansion underway with up to 10 additional state licenses pending
- Strong calendar 2026 performance signals positive trajectory for fiscal Q4
MIAMI, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential operating businesses, today announced its financial and operational results for the third fiscal quarter ended December 31, 2025.
“We exited the third fiscal quarter with strong strategic momentum and continued progress across our diversified platform,” said Giorgio R. Saumat, CEO and Chairman of the Board of Earth Science Tech, Inc. “Results were largely consistent with the prior quarter and reflected typical seasonality, including holiday timing and temporary macro and supply-related headwinds. Importantly, multiple operating units are now generating positive cash flow, underscoring the strength and resilience of our portfolio approach.”
Mr. Saumat continued, “While our reported results reflect the current stage of our growth and investment cycle, they do not yet fully capture the operating leverage inherent in the model. Moving ahead, we see a clear and verifiable path to a materially higher earnings baseline through expense rationalization and scale, a view reinforced by our ongoing share repurchases and my long‑term ownership position acquired entirely with cash. With calendar 2026 off to a strong start and several geographic and product expansion initiatives underway, we believe the Company is well positioned for accelerating growth in the periods ahead.”
Fiscal Q3 2026 Key Financial Highlights
- Revenue of
$8.4 million , up14.1% compared to$7.4 million for the three months ended December 31, 2024 - Gross profit of
$6.4 million , or a gross margin of76.3% , as compared to$5.1 million or a gross margin of69.2% , for the three months ended December 31, 2024, an increase of$1.3 million , or25.8% on a dollar basis - Net Income of
$910,000 , up341.0% compared to$206,000 for the three months ended December 31, 2024 - Total Assets of
$8.1 million , up14.5% compared to$7.1 million at March 31, 2025 - Repurchased and retired 3,703,296 shares of common stock for the nine months ended December 31, 2025
Third Fiscal Quarter 2026 Financial Results
Revenue
Revenue for the three months ended December 31, 2025, was
Gross Profit/Margin
Gross profit for the third quarter of fiscal 2026 was
Operating Expenses
For the three months ended December 31, 2025, operating expenses were
Net Income
Net income was
Adjusted EBITDA
Adjusted EBITDA was
Balance Sheet
As of December 31, 2025, the Company had
The Company repurchased and retired 1,143,000 and 3,703,296 shares of its common stock for the three and nine months ended December 31, 2025, respectively.
Conference Call and Webcast:
The Company will host a conference call and webcast to discuss its second fiscal quarter results, highlights, and outlook at 5:00 Eastern Time. To participate in the telephone conference call please dial in at least 15 minutes prior to start time.
Conference Call Information
Date: Tuesday, February 17, 2026
Time: 5 p.m. Eastern Time
Toll Free: 1 800-450-7155 Code: 9041018#
International: +1 857-999-9155 Code: 9041018#
Live Webcast Link: https://www.cstproxy.com/earthsciencetech/earnings/2025/q3/
Conference Call Replay Information
Replay Webcast Link: https://www.cstproxy.com/earthsciencetech/earnings/2025/q3/
Non-GAAP Measures
In addition to disclosing financial results in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), this document references certain non-GAAP financial measures. The Company defines Adjusted EBITDA as earnings excluding interest, tax, depreciation and amortization. We believe these non-GAAP financial measures provide investors with useful supplemental information about our operating performance and enable comparison of financial trends and results between periods where certain items may vary, independent of business performance.
Please refer to “Reconciliation of Non-GAAP Measures” in this document for a detailed explanation of the adjustments made to the comparable U.S. GAAP measures.
About Earth Science Tech, Inc. (ETST)
Earth Science Tech, Inc. is a diversified holding company focused on the health and wellness sector. Through its wholly-owned subsidiaries, ETST operates a vertically integrated portfolio that includes high-quality compounding pharmacies, telemedicine platforms, and targeted healthcare facilities. The Company currently owns RxCompoundStore.com and Mister Meds, two licensed compounding pharmacies providing sterile and non-sterile medications across a growing network of U.S. states. These operations are supported by Peaks Curative, DOConsultation.com, and Las Villas Health Care, providing patients with personalized care, telemedicine connectivity, and clinical support.
Beyond healthcare, ETST manages Avenvi, its real estate and asset management arm, and
To learn more, please visit: www.EarthScienceTech.com
Forward-Looking Statements
Except for historical information, the matters discussed herein may be considered “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.
Such statements include declarations regarding the intent, belief or current expectations of the Company and its management, including, without limitation, future-oriented statements related to cash flow, gross margins, revenues, and expenses. These statements are based on and reflect our current expectations, estimates, assumptions and/or projections, our perception of historical trends and current conditions, as well as other factors that we believe are appropriate and reasonable under the circumstances. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts. They may include forward-looking words such as “expect,” “expectation,” “believe,” “anticipate,” “may,” “could,” “intend,” “belief,” “plan,” “estimate,” “target,” “predict,” “likely,” “seek,” “project,” “model,” “ongoing,” “will,” “should,” “forecast,” “outlook” or similar terminology. Forward-looking statements are subject to a number of risks and uncertainties that may cause the Company’s actual results to differ materially from our intent, belief or current expectations, including, inter alia, the markets for the Company’s products and services, costs of goods and services, other expenses, government regulations, litigations, and general business conditions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.
Contact:
Hayden IR
James Carbonara
(646)-755-7412
james@haydenir.com
Brett Maas
(646) 536-7331
brett@haydenir.com
-- Tables Follow --
Earth Science Tech, Inc. and Subsidiaries
Consolidated Balance Sheets
(Unaudited)
| As of December 31, 2025 | As of March 31, 2025 | |||||||
| ASSETS | ||||||||
| Current Assets: | ||||||||
| Cash and cash equivalents | $ | 415,699 | $ | 1,473,228 | ||||
| Accounts Receivable | 306,118 | 129,064 | ||||||
| Equity Investments at fair value | 1,126,307 | 645,438 | ||||||
| Inventory | 1,088,019 | 503,938 | ||||||
| Deposits | 57,631 | 338,108 | ||||||
| Prepaid | 39,159 | 20,730 | ||||||
| Total current assets | 3,032,933 | 3,110,505 | ||||||
| Non-Current Assets: | ||||||||
| Property and Equipment, net | 1,890,801 | 1,384,110 | ||||||
| Right of use asset, net | 139,231 | 172,429 | ||||||
| Goodwill | 2,648,788 | 2,302,792 | ||||||
| Intangible Assets, net | 377,684 | 96,885 | ||||||
| Total Assets | $ | 8,089,437 | $ | 7,066,721 | ||||
| LIABILITIES AND EQUITY | ||||||||
| Accounts payable | $ | 1,088,521 | $ | 492,352 | ||||
| Accrued expenses and other payable | 1,019,036 | 2,322,022 | ||||||
| Current portion of operating lease obligations | 121,851 | 121,851 | ||||||
| Current portion of equipment loan | 30,592 | 30,592 | ||||||
| Short-term business loan | - | 179,488 | ||||||
| Total Current Liabilities | 2,260,000 | 3,146,305 | ||||||
| Long-Term Liabilities: | ||||||||
| Lease liability less current maturities | 18,177 | 37,878 | ||||||
| Equipment loan, non-current | 8,254 | 31,427 | ||||||
| Total Liabilities | 2,286,431 | 3,215,610 | ||||||
| Commitment and Contingencies (Note 11) | ||||||||
| Stockholders’ Equity: | ||||||||
| Preferred stock, par value | 1,000 | 1,000 | ||||||
| Common stock, par value | 291,644 | 295,348 | ||||||
| Additional paid-in capital | 30,836,759 | 31,480,143 | ||||||
| Accumulated deficit | (25,396,738 | ) | (27,738,975 | ) | ||||
| Treasury Stock, at cost 35,000 and 1,045,296 shares as of December 31, 2025, and March 31, 2025, respectively | (5,525 | ) | (186,404 | ) | ||||
| Non-Controlling Interest | 75,866 | - | ||||||
| Total stockholders’ Equity | 5,803,006 | 3,851,111 | ||||||
| Total Liabilities and Equity | $ | 8,089,437 | $ | 7,066,721 | ||||
Earth Science Tech, Inc. and Subsidiaries
Consolidated Statements of Operations
For Three and Nine months ended December 31, 2025, and 2024
(Unaudited)
| For the Three Months Ended December 31, | For the Nine Months Ended December 31, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Revenue | $ | 8,386,779 | 7,352,635 | $ | 26,197,596 | $ | 24,440,600 | |||||||||
| Cost of Goods Sold | 1,987,769 | 2,265,762 | 6,983,827 | 6,676,612 | ||||||||||||
| Gross Profit | 6,399,010 | 5,086,873 | 19,213,769 | 17,763,988 | ||||||||||||
| Expenses | ||||||||||||||||
| Salaries Expense | 2,931,244 | 3,297,826 | 10,787,357 | 10,372,308 | ||||||||||||
| Office/Selling, General and Administrative Expenses | 914,029 | 809,850 | 2,741,912 | 3,455,474 | ||||||||||||
| Advertising & marketing | 708,511 | 346,109 | 2,082,463 | 511,455 | ||||||||||||
| Bank charges | 250,332 | 210,549 | 725,340 | 770,849 | ||||||||||||
| Legal & Professional Fees | 56,022 | 61,540 | 138,141 | 243,245 | ||||||||||||
| Insurance | 40,318 | 79,569 | 126,863 | 160,395 | ||||||||||||
| Depreciation and Amortization | 121,790 | 44,778 | 342,751 | 108,201 | ||||||||||||
| Utilities | 34,743 | 10,426 | 102,769 | 21,257 | ||||||||||||
| Total Expenses | 5,056,988 | 4,860,647 | 17,047,597 | 15,643,184 | ||||||||||||
| Other Income/Expenses | ||||||||||||||||
| Dividend Income | 4,537 | 9,123 | 13,944 | 9,123 | ||||||||||||
| Interest earned | 457 | 16 | 2,259 | 13,216 | ||||||||||||
| Net realized gain on sale of investments | 309,807 | 174,613 | 536,951 | 174,613 | ||||||||||||
| Unrealized Gain/Loss of fair value changes of investments | (613,741 | ) | (197,277 | ) | (262,067 | ) | (197,277 | ) | ||||||||
| Interest Expenses | (4,769 | ) | (6,290 | ) | (16,335 | ) | (11,097 | ) | ||||||||
| Net Income before taxes | 1,038,314 | 206,411 | 2,440,925 | 2,109,382 | ||||||||||||
| Income Tax | 127,946 | - | 127,946 | 28,349 | ||||||||||||
| Net Income | 910,367 | 206,411 | 2,312,978 | 2081,033 | ||||||||||||
| Net Income/(Loss) attributed to non-controlling interest | (9 | ) | - | (29,250 | ) | - | ||||||||||
| Net Income attributed to shareholders | 910,376 | 206,411 | 2,342,237 | 2,081,382 | ||||||||||||
| Net Income per common share-Basic and Diluted | 0.003 | 0.001 | 0.008 | 0.007 | ||||||||||||
| Weighted average number of common shares outstanding basic and diluted | 292,804,167 | 302,885,823 | 293,564,655 | 306,278,649 | ||||||||||||